; pSivida Reports Updates on ILUVIEN® for Planned Resubmission to FDA and European Launch
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

pSivida Reports Updates on ILUVIEN® for Planned Resubmission to FDA and European Launch

VIEWS: 0 PAGES: 3

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports that its licensee Alimera Sciences to refile with FDA for Iluvien for DME before end of Month; Iluvien launch in Europe to commence in second quarter 2013 img border='0' title='Add to Google' alt='Add to Google' src='http://imag

More Info
To top